L. Johnston, Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity, Best Practice & Research Clinical Haematology, vol.21, issue.2, pp.177-192, 2008.
DOI : 10.1016/j.beha.2008.02.006

F. Baron, M. Labopin, D. Niederwieser, S. Vigouroux, J. J. Cornelissen et al., Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation, Leukemia, vol.11, issue.12, pp.2462-2468, 2012.
DOI : 10.1056/NEJMoa1108188

S. W. Choi, P. Stiff, K. Cooke, J. L. Ferrara, T. Braun et al., TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes, Biology of Blood and Marrow Transplantation, vol.18, issue.10, pp.1525-1532, 2012.
DOI : 10.1016/j.bbmt.2012.03.013

J. L. Ferrara, J. E. Levine, P. Reddy, and E. Holler, Graft-versus-host disease, The Lancet, vol.373, issue.9674, pp.1550-1561, 2009.
DOI : 10.1016/S0140-6736(09)60237-3

B. R. Blazar, W. J. Murphy, and M. Abedi, Advances in graft-versus-host disease biology and therapy, Nature Reviews Immunology, vol.69, issue.6, pp.443-458, 2012.
DOI : 10.1038/nri3212

M. Remberger, O. Ringden, and L. Markling, TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD, Bone Marrow Transplant, vol.15, pp.99-104, 1995.

S. W. Choi, C. L. Kitko, T. Braun, S. Paczesny, G. Yanik et al., Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival, Blood, vol.112, issue.4, pp.1539-1542, 2008.
DOI : 10.1182/blood-2008-02-138867

R. M. Dean, T. Fry, C. Mackall, S. M. Steinberg, F. Hakim et al., Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease, Journal of Clinical Oncology, vol.26, issue.35, pp.5735-5741, 2008.
DOI : 10.1200/JCO.2008.17.1314

S. Thiant, M. Labalette, J. Trauet, V. Coiteux, E. De-berranger et al., Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD, Bone Marrow Transplantation, vol.119, issue.10, pp.1374-1381, 2011.
DOI : 10.1038/bmt.2010.300

S. Thiant, I. Yakoub-agha, L. Magro, J. Trauet, V. Coiteux et al., Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse, Bone Marrow Transplantation, vol.177, issue.10, pp.1546-1552, 2010.
DOI : 10.1038/sj.leu.2404892

D. Liu, C. Yan, L. Xu, Y. Wang, W. Han et al., Diarrhea during the Conditioning Regimen Is Correlated with the Occurrence of Severe Acute Graft-versus-Host Disease through Systemic Release of Inflammatory Cytokines, Biology of Blood and Marrow Transplantation, vol.16, issue.11, pp.1567-1575, 2010.
DOI : 10.1016/j.bbmt.2010.05.001

S. Paczesny, O. I. Krijanovski, T. M. Braun, S. W. Choi, S. G. Clouthier et al., A biomarker panel for acute graft-versus-host disease, Blood, vol.113, issue.2, pp.273-278, 2009.
DOI : 10.1182/blood-2008-07-167098

K. J. August, K. Y. Chiang, R. M. Bostick, W. D. Flanders, E. K. Waller et al., Biomarkers of immune activation to screen for severe, acute GVHD, Bone Marrow Transplantation, vol.103, issue.4, pp.601-604, 2011.
DOI : 10.1097/00007890-197410000-00001

A. Bacigalupo, K. Ballen, D. Rizzo, S. Giralt, H. Lazarus et al., Defining the Intensity of Conditioning Regimens: Working Definitions, Biology of Blood and Marrow Transplantation, vol.15, issue.12, pp.1628-1633, 2009.
DOI : 10.1016/j.bbmt.2009.07.004

R. J. Epstein, G. B. Mcdonald, G. E. Sale, H. M. Shulman, and E. D. Thomas, The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients, Gastroenterology, vol.78, pp.764-771, 1980.

T. Imai, K. Hieshima, C. Haskell, M. Baba, M. Nagira et al., Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion, Cell, vol.91, issue.4, pp.521-530, 1997.
DOI : 10.1016/S0092-8674(00)80438-9

S. Goda, T. Imai, O. Yoshie, O. Yoneda, H. Inoue et al., CX3C-Chemokine, Fractalkine-Enhanced Adhesion of THP-1 Cells to Endothelial Cells Through Integrin-Dependent and -Independent Mechanisms, The Journal of Immunology, vol.164, issue.8, pp.4313-4320, 2000.
DOI : 10.4049/jimmunol.164.8.4313

A. M. Fong, L. A. Robinson, D. A. Steeber, T. F. Tedder, O. Yoshie et al., CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow, The Journal of Experimental Medicine, vol.156, issue.8, pp.1413-1419, 1998.
DOI : 10.1083/jcb.135.3.837

S. N. Cox, F. Sallustio, G. Serino, A. Loverre, F. Pesce et al., Activated innate immunity and the involvement of CX3CR1???fractalkine in promoting hematuria in patients with IgA nephropathy, Kidney International, vol.82, issue.5, pp.548-560, 2012.
DOI : 10.1038/ki.2012.147

G. Socié and B. R. Blazar, Acute graft-versus-host disease: from the bench to the bedside, Blood, vol.114, issue.20, pp.4327-4336, 2009.
DOI : 10.1182/blood-2009-06-204669

R. Sackstein, A Revision of Billingham???s Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.12, issue.1, pp.2-8, 2006.
DOI : 10.1016/j.bbmt.2005.09.015

Y. Zhang, J. P. Louboutin, J. Zhu, A. J. Rivera, and S. G. Emerson, Preterminal host dendritic cells in irradiated mice prime CD8+ T cell???mediated acute graft-versus-host disease, Journal of Clinical Investigation, vol.109, issue.10, pp.1335-1344, 2002.
DOI : 10.1172/JCI0214989

W. D. Shlomchik, M. S. Couzens, C. B. Tang, J. Mcniff, M. E. Robert et al., Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells, Science, vol.285, issue.5426, pp.412-415, 1999.
DOI : 10.1126/science.285.5426.412

C. C. Matte, J. Liu, J. Cormier, B. E. Anderson, I. Athanasiadis et al., Donor APCs are required for maximal GVHD but not for GVL, Nature Medicine, vol.90, issue.9, pp.987-992, 2004.
DOI : 10.1172/JCI200317601

T. A. Springer, Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm, Cell, vol.76, issue.2, pp.301-314, 1994.
DOI : 10.1016/0092-8674(94)90337-9

T. Hori, Y. Naishiro, H. Sohma, N. Suzuki, N. Hatakeyama et al., CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease, Blood, vol.111, issue.8, pp.4403-4412, 2008.
DOI : 10.1182/blood-2007-06-097287

K. P. Piper, C. Horlock, S. J. Curnow, J. Arrazi, S. Nicholls et al., CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation, Blood, vol.110, issue.12, pp.3827-3832, 2007.
DOI : 10.1182/blood-2006-12-061408

R. Reshef, S. M. Luger, E. O. Hexner, A. W. Loren, N. V. Frey et al., Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease, New England Journal of Medicine, vol.367, issue.2, pp.135-145, 2012.
DOI : 10.1056/NEJMoa1201248

K. J. Garton, P. J. Gough, C. P. Blobel, G. Murphy, D. R. Greaves et al., Tumor necrosis factor-alphaconverting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1), J. Biol. Chem, vol.276, pp.37993-38001, 2001.

C. Hundhausen, D. Misztela, T. A. Berkhout, N. Broadway, P. Saftig et al., The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion, Blood, vol.102, issue.4, pp.1186-1195, 2003.
DOI : 10.1182/blood-2002-12-3775

C. L. Tsou, C. A. Haskell, and I. F. Charo, Tumor Necrosis Factor-alpha -converting Enzyme Mediates the Inducible Cleavage of Fractalkine, Journal of Biological Chemistry, vol.276, issue.48, pp.44622-44626, 2001.
DOI : 10.1074/jbc.M107327200

J. F. Bazan, K. B. Bacon, G. Hardiman, W. Wang, K. Soo et al., A new class of membrane-bound chemokine with a CX3C motif, Nature, vol.385, issue.6617, pp.640-644, 1997.
DOI : 10.1038/385640a0

G. E. Garcia, Y. Xia, S. Chen, Y. Wang, R. D. Ye et al., NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS, J. Leukoc. Biol, vol.67, pp.577-584, 2000.

F. Marchesi, M. Locatelli, G. Solinas, M. Erreni, P. Allavena et al., Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer, Journal of Neuroimmunology, vol.224, issue.1-2, pp.39-44, 2010.
DOI : 10.1016/j.jneuroim.2010.05.007

M. Nishimura, H. Umehara, T. Nakayama, O. Yoneda, K. Hieshima et al., Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression, The Journal of Immunology, vol.168, issue.12, pp.6173-6180, 2002.
DOI : 10.4049/jimmunol.168.12.6173

N. Tong, S. W. Perry, Q. Zhang, H. J. James, H. Guo et al., Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System, The Journal of Immunology, vol.164, issue.3, pp.1333-1339, 2000.
DOI : 10.4049/jimmunol.164.3.1333

H. Umehara, E. T. Bloom, T. Okazaki, Y. Nagano, O. Yoshie et al., Fractalkine in Vascular Biology: From Basic Research to Clinical Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.1, pp.34-40, 2004.
DOI : 10.1161/01.ATV.0000095360.62479.1F

D. 'haese, J. G. Demir, I. E. Friess, H. Ceyhan, and G. O. , Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential, Expert Opinion on Therapeutic Targets, vol.48, issue.2, pp.207-219, 2010.
DOI : 10.1016/S1074-7613(00)80165-X

O. Medina-contreras, D. Geem, O. Laur, I. R. Williams, S. A. Lira et al., CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice, Journal of Clinical Investigation, vol.121, issue.12, pp.4787-4795, 2011.
DOI : 10.1172/JCI59150DS1

C. Mionnet, V. Buatois, A. Kanda, V. Milcent, S. Fleury et al., CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung, Nature Medicine, vol.16, issue.11, pp.1305-1312, 2010.
DOI : 10.1038/nm.2253

URL : https://hal.archives-ouvertes.fr/hal-00726050

B. Broux, K. Pannemans, X. Zhang, S. Markovic-plese, T. Broekmans et al., CX3CR1 drives cytotoxic CD4+CD28??? T cells into the brain of multiple sclerosis patients, 2012) CX(3)CR1 drives cytotoxic CD4(+)CD28, pp.10-19
DOI : 10.1016/j.jaut.2011.11.006

T. K. Tarrant, P. Liu, R. R. Rampersad, D. Esserman, L. R. Rothlein et al., Decreased Th17 and antigen-specific humoral responses in CX3CR1-deficient mice in the collagen-induced arthritis model, Arthritis & Rheumatism, vol.278, issue.5, pp.1379-1387, 2012.
DOI : 10.1002/art.34320

M. Sasaki, M. Miyakoshi, Y. Sato, and Y. Nakanuma, Chemokine???Chemokine Receptor CCL2???CCR2 and CX3CL1???CX3CR1 Axis May Play a Role in the Aggravated Inflammation in Primary Biliary Cirrhosis, Digestive Diseases and Sciences, vol.183, issue.2, pp.358-364, 2014.
DOI : 10.1007/s10620-013-2920-6

A. El-shazly, P. Berger, P. O. Girodet, O. Ousova, M. Fayon et al., Fraktalkine Produced by Airway Smooth Muscle Cells Contributes to Mast Cell Recruitment in Asthma, The Journal of Immunology, vol.176, issue.3, pp.1860-1868, 2006.
DOI : 10.4049/jimmunol.176.3.1860

F. Suzuki, T. Nanki, T. Imai, H. Kikuchi, S. Hirohata et al., Inhibition of CX3CL1 (Fractalkine) Improves Experimental Autoimmune Myositis in SJL/J Mice, The Journal of Immunology, vol.175, issue.10, pp.6987-6996, 2005.
DOI : 10.4049/jimmunol.175.10.6987

W. L. Jamieson, S. Shimizu, J. A. D-'ambrosio, O. Meucci, and A. Fatatis, CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism, Cancer Research, vol.68, issue.6, pp.1715-1722, 2008.
DOI : 10.1158/0008-5472.CAN-07-1315

F. Marchesi, L. Piemonti, G. Fedele, A. Destro, M. Roncalli et al., The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma, Cancer Research, vol.68, issue.21, pp.9060-9069, 2008.
DOI : 10.1158/0008-5472.CAN-08-1810

J. Lu, P. S. Steeg, J. E. Price, S. Krishnamurthy, S. A. Mani et al., Breast Cancer Metastasis: Challenges and Opportunities, Cancer Research, vol.69, issue.12, pp.4951-4953, 2009.
DOI : 10.1158/0008-5472.CAN-09-0099

A. Corcione, E. Ferretti, and V. Pistoia, CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function, Journal of Leukocyte Biology, vol.92, issue.1, pp.51-58, 2012.
DOI : 10.1189/jlb.0112035

J. Ren, X. Y. Hou, S. H. Ma, F. K. Zhang, J. H. Zhen et al., Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia, Journal of Internal Medicine, vol.33, issue.Suppl 1, pp.512-524, 2014.
DOI : 10.1111/joim.12218

M. Murai, H. Yoneyama, A. Harada, Z. Yi, C. Vestergaard et al., Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease, Journal of Clinical Investigation, vol.104, issue.1, pp.49-57, 1999.
DOI : 10.1172/JCI6642

L. A. Palmer, G. E. Sale, J. I. Balogun, D. Li, D. Jones et al., Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.16, issue.3, pp.311-319, 2010.
DOI : 10.1016/j.bbmt.2009.12.002

T. A. Graubert, J. F. Dipersio, J. H. Russell, and T. J. Ley, Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation., Journal of Clinical Investigation, vol.100, issue.4, pp.904-911, 1997.
DOI : 10.1172/JCI119606

B. R. Blazar, P. A. Taylor, and D. A. Vallera, CD4+ AND CD8+ T CELLS EACH CAN UTILIZE A PERFORIN-DEPENDENT PATHWAY TO MEDIATE LETHAL GRAFT-VERSUS-HOST DISEASE IN MAJOR HISTOCOMPATIBILITY COMPLEX-DISPARATE RECIPIENTS1, Transplantation, vol.64, issue.4, pp.571-576, 1997.
DOI : 10.1097/00007890-199708270-00004

C. Schmaltz, O. Alpdogan, K. J. Horndasch, S. J. Muriglan, B. J. Kappel et al., Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect, Blood, vol.97, issue.9, pp.2886-2895, 2001.
DOI : 10.1182/blood.V97.9.2886

M. H. Hsieh and R. Korngold, Differential use of FasL-and perforinmediated cytolytic mechanisms by T-cell subsets involved in graft-versusmyeloid leukemia responses, Blood, vol.96, pp.1047-1055, 2000.

P. Fraticelli, M. Sironi, G. Bianchi, D. D-'ambrosio, C. Albanesi et al., Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses, Journal of Clinical Investigation, vol.107, issue.9, pp.1173-1181, 2001.
DOI : 10.1172/JCI11517

T. Teshima, Th1 and Th17 join forces for acute GVHD, Blood, vol.118, issue.18, pp.4765-4767, 2011.
DOI : 10.1182/blood-2011-09-377325

J. L. Ferrara, A. C. Harris, J. K. Greenson, T. M. Braun, E. Holler et al., Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease, Blood, vol.118, issue.25, pp.6702-6708, 2011.
DOI : 10.1182/blood-2011-08-375006